ProteoWise

📍 New Haven, United States👥 11 employees💰 Last funded Mar 2020
Biotechnology Research🌐 proteowise.com
Website LinkedIn
Bringing the Power of Proteomics to Every Lab Bench! ProteoWise is revolutionizing multiplex protein analysis with the Hyperblot System. The Problem: Proteomics is hard to do at the lab bench. Traditional western blot analysis is cumbersome, consumes a lot of sample and yields very little data per run. This bottleneck makes proteomic hypothesis investigation very difficult. The Solution: ProteoWise has developed a product with an immortalized membrane that captures and covalently binds protein, allowing hundreds of targets to be rapidly analyzed on the same sample - today, tomorrow, next year – this allows focused, limitless proteomic interrogation for the first time.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ProteoWise?
ProteoWise has 1 investors on record on gritt.io.
When did ProteoWise last raise funding?
The most recent investment in ProteoWise recorded on gritt.io was in March 2020.
What industry is ProteoWise in?
ProteoWise operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ProteoWise based?
ProteoWise is headquartered in New Haven, United States.